skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

74 Total results for product and free and sample content found


2017 Completed Trials

By Christine Blazynski, PhD 19 Oct 2018

As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.

Topic Clinical trials

Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

By Laura Runkel 19 Oct 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.


Pharma Partnering Trends Revealed Whitepaper

12 Oct 2018

Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.

Datamonitor Healthcare

Epidiolex and Epilepsy - big changes for medical marijuana

By Stephanie Yip 28 Aug 2018

With the FDA’s landmark approval of Epidiolex, a cannabidiol used to treat rare, severe pediatric epilepsies, the only obstacle to the legal sale of the drug is DEA reclassification of cannabidiol (CBD). With reclassification likely in the next 90 days, what does it mean for the epilepsy market, as well as the wider market for CBD?

Topic Drug approval

Pharma Consulting

Changing the future of data

17 Aug 2018

With fewer successful drug launches in the market and expiring patents, competitive intelligence and commercial R&D decision makers are hard-pressed to make sound forecasting and planning decisions based on highly reliable data analysis. That’s a big challenge because, even with access to big data from many sources, the tasks associated with collecting, organizing and mapping data sets is time-consuming, costly and labour-intensive. As result, decision making takes longer and innovation suffers.

Topic Business strategies Company analysis

Pharmaprojects, Citeline

Pharma R&D Annual Review 2018

By Ian Lloyd 15 May 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Topic Research

Pharma Consulting

Pharma Consulting 2018 Brochure

15 May 2018

With Pharma Consulting services, you tap into the expertise of our experienced consultants who leverage the data, resources and . expertise of our market-leading intelligence sources and develop authoritative. Download the Pharma Consulting brochure, which includes contact information and discover the power of our consulting solutions.

In Vivo

Success In Oncology Whitepaper

10 May 2018

Looking for your path to success in oncology? Stay on top of the rapidly accelerating complexity of oncology drug development with the crucial insights into cancer treatments that only In Vivo can provide – now yours as a free download.

Topic Cancer

Pharma Consulting

Pharma Consulting Whitepaper

30 Apr 2018

Accurate benchmarking has never been more important to the biopharma industry than now, with increased scrutiny related to development costs at an all-time high. What benchmarks are you using? How does your development program compare to those of your competitors? Explore the importance of benchmarking, specificity, and consulting as they relate to drug development approval rates in biopharma with Pharma Consulting - Probabilities of Technical Success in Biopharma, the informative whitepaper from Informa’s Pharma Consulting.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: